Next Article in Journal
New Approach for Studying of Isoforms and High-Homology Proteins in Mammalian Cells
Next Article in Special Issue
Lipid Peroxidation-Related Redox Signaling in Osteosarcoma
Previous Article in Journal
Blood–Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework
Previous Article in Special Issue
Gold Nanoparticles Inhibit Extravasation of Canine Osteosarcoma Cells in the Ex Ovo Chicken Embryo Chorioallantoic Membrane Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 15
10.3390/ijms241512155
Review Report
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article
Peer-Review Record

The Role of FAS Receptor Methylation in Osteosarcoma Metastasis

Int. J. Mol. Sci. 2023, 24(15), 12155; https://doi.org/10.3390/ijms241512155
by Jiayi M. Sun 1,2, Wing-Yuk Chow 2,3,†, Gufeng Xu 2,3, M. John Hicks 4, Manjula Nakka 2,3, Jianhe Shen 2,3, Patrick Kwok Shing Ng 5, Aaron M. Taylor 1,2,5, Alexander Yu 2,3, Jason E. Farrar 6, Donald A. Barkauskas 7, Richard Gorlick 8, Jaime M. Guidry Auvil 9, Daniela Gerhard 9,†, Paul Meltzer 10, Rudy Guerra 11, Tsz-Kwong Man 1,2,3, Ching C. Lau 1,2,3,5,12,* and on behalf of the TARGET Osteosarcoma Consortium ‡
Reviewer 1:
Sulev Kõks
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2023, 24(15), 12155; https://doi.org/10.3390/ijms241512155
Submission received: 28 June 2023 / Revised: 26 July 2023 / Accepted: 27 July 2023 / Published: 29 July 2023
(This article belongs to the Special Issue Osteosarcoma: Current Advances from Molecular and Cellular Mechanisms to Therapy)

Round 1

Reviewer 1 Report

This is a good paper describing FAS methylation and methylation regulation.

It is an excellent experimental study with new data and results. 

Some comments

1. The discussion does not have much information on how common alterations of FAS and FASL expression in osteosarcoma or other sarcomas and carcinomas are.

2. Osteoasraciom has a couple of studies describing the gene expression profiles and integrative genomic data analysis (PMID: 29050494, 25496518). Maybe authors can check these articles to get comparative data for their manuscript.

3. This comparison is important to improve the translational potential of the mansucript.

 

Author Response

Please see the attachment.

 

Author Response File: Author Response.pdf

Reviewer 2 Report

Dear Authors,

The role of FAS receptor methylation in osteosarcoma metastasis by Sun et al is interesting. However, the current version of the manuscript needs some additional data or information to improve the quality of the manuscript to publish in IJMS journal.

 

Major comments.

Comments: 1.  Authors could show the % of wounder closer (graphical representation) compared to control, 5 mM and 10 5 mM in Figure 3 will be nice.

 

Comments: 2.    Nice to see the 5-Aza kill curve at least in cells.

 

Comments: 3.   Please include vehicle injected mice (control with no tumor mice) in IHC. This will help to see the real survival of the mice.

 

Comments: 4.  The authors using 5-Aza to inhibit DNMT activity. It will be nice to see the DNMT1 and DNMT3 immunoblot before after the treatment in cells as well as in tumor samples.

 

 

 

Minor English correction needed

Author Response

Please see the attachment.

 

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

The manuscript is improved

Author Response

Dear reviewer,

Thank you for your positive review.

Sincerely,
Aaron Taylor

Back to TopTop